Brian Larson
Radiation Oncology · Homewood, ALNPI 1861498370
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,323 and has fallen 92.4% since, to $100 in 2024.
Across 143 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dendreon Pharmaceuticals LLC$442
- Johnson & Johnson$352
- Novartis$287
- Bayer$211
- Pfizer$186
- Sanofi$134
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,71496%
- Education$1064%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 16 | $442 |
| Johnson & Johnson | 24 | $352 |
| Novartis | 14 | $287 |
| Bayer | 11 | $211 |
| Pfizer | 12 | $186 |
| Sanofi | 5 | $134 |
| Astellas Pharma US Inc | 7 | $122 |
| E.r. Squibb & Sons, L.L.C. | 8 | $114 |
| AbbVie | 1 | $106 |
| Tempus AI, Inc | 4 | $100 |
| Amgen | 6 | $90 |
| Exelixis Inc. | 5 | $76 |
| Varian Medical Systems, Inc. | 2 | $73 |
| Sun Pharmaceutical Industries Inc. | 3 | $72 |
| AstraZeneca | 4 | $61 |
| Neotract Inc. | 1 | $56 |
| Eisai Inc. | 3 | $47 |
| Myriad Genetic Laboratories, Inc. | 2 | $41 |
| Medtronic | 2 | $32 |
| Merck | 2 | $29 |
| Tolmar, Inc. | 1 | $27 |
| Axonics, Inc. | 2 | $26 |
| Blue Earth Diagnostics | 1 | $22 |
| Mylan Institutional Inc. | 1 | $19 |
| EMD Serono, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Angiodynamics, Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Myovant Sciences Inc. | 1 | $15 |
| Seagen Inc. | 1 | $15 |
How this compares
$2,819 in reported general payments places this provider in the 70th percentile of 87 radiation oncology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 14 | $37,706 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Homewood
- Jacob LangstonHomewood$2K
- Alexander WhitleyMontgomery$441K
- Drexell BoggsBirmingham$35K
- Christopher JahrausAlabaster$28K
- Christopher WilleyBirmingham$13K
- Adam KoleBirmingham$11K
- William HixsonFairhope$10K
- John GleasonHuntsville$9K
- Andrew McDonaldBirmingham$8K
- Hoyt ChildsHuntsville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.